Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Genovefa A Papanicolaou

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
Current Infectious Disease Reports|November 17, 2019
CMV Prevention and Treatment in Transplantation: What's New in 2019Anat Stern, Genovefa A Papanicolaou
Expert Opinion on Investigational Drugs|October 21, 2025
Investigational treatments for cytomegalovirus infection in phase I and II studyMorgan Hakki, Anat Stern, Genovefa A Papanicolaou
Viruses|July 27, 2024
Refractory/Resistant Cytomegalovirus Infection in Transplant Recipients: An UpdateLéna Royston, Genovefa A Papanicolaou, Dionysios Neofytos
Blood|December 9, 2022
How I prevent viral reactivation in high-risk patientsSanjeet S Dadwal, Genovefa A Papanicolaou, Michael Boeckh
Current Opinion in Infectious Diseases|June 30, 2017
Approach to adenovirus infections in the setting of hematopoietic cell transplantationYeon Joo Lee, Susan E Prockop, Genovefa A Papanicolaou
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 21, 2023
CMV prevention strategies in allogeneic hematopoietic cell transplantation; the role of prophylaxis and pre-emptive monitoring in the era of letermovirMichelle K Yong, Monica A Slavin, Roy F Chemaly, et al.
The Journal of Antimicrobial Chemotherapy|January 6, 2018
Echinocandin prophylaxis in patients undergoing haematopoietic cell transplantation and other treatments for haematological malignanciesDavid J Epstein, Susan K Seo, Janice M Brown, et al.
Transplant Immunology|November 15, 2022
Concurrent pulmonary Aspergillus and non-Aspergillus mold infections in allogeneic hematopoetic cell transplant recipientsVarshini Gali, Anna Kaltsas, Melvilí Cintrón, et al.
Transplantation and Cellular Therapy|March 29, 2021
Economic and Clinical Burden of Virus-Associated Hemorrhagic Cystitis in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation in the United StatesJoseph McGuirk, Clint Divine, Seung Hyun Moon, et al.
Journal of Clinical Microbiology|November 8, 2019
False-Positive Results for Human Immunodeficiency Virus Type 1 Nucleic Acid Amplification Testing in Chimeric Antigen Receptor T Cell TherapyJocelyn R Hauser, Hong Hong, N Esther Babady, et al.
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
Current Infectious Disease Reports|November 17, 2019
CMV Prevention and Treatment in Transplantation: What's New in 2019Anat Stern, Genovefa A Papanicolaou
Expert Opinion on Investigational Drugs|October 21, 2025
Investigational treatments for cytomegalovirus infection in phase I and II studyMorgan Hakki, Anat Stern, Genovefa A Papanicolaou
Viruses|July 27, 2024
Refractory/Resistant Cytomegalovirus Infection in Transplant Recipients: An UpdateLéna Royston, Genovefa A Papanicolaou, Dionysios Neofytos
Blood|December 9, 2022
How I prevent viral reactivation in high-risk patientsSanjeet S Dadwal, Genovefa A Papanicolaou, Michael Boeckh
Current Opinion in Infectious Diseases|June 30, 2017
Approach to adenovirus infections in the setting of hematopoietic cell transplantationYeon Joo Lee, Susan E Prockop, Genovefa A Papanicolaou
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 21, 2023
CMV prevention strategies in allogeneic hematopoietic cell transplantation; the role of prophylaxis and pre-emptive monitoring in the era of letermovirMichelle K Yong, Monica A Slavin, Roy F Chemaly, et al.
The Journal of Antimicrobial Chemotherapy|January 6, 2018
Echinocandin prophylaxis in patients undergoing haematopoietic cell transplantation and other treatments for haematological malignanciesDavid J Epstein, Susan K Seo, Janice M Brown, et al.
Transplant Immunology|November 15, 2022
Concurrent pulmonary Aspergillus and non-Aspergillus mold infections in allogeneic hematopoetic cell transplant recipientsVarshini Gali, Anna Kaltsas, Melvilí Cintrón, et al.
Transplantation and Cellular Therapy|March 29, 2021
Economic and Clinical Burden of Virus-Associated Hemorrhagic Cystitis in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation in the United StatesJoseph McGuirk, Clint Divine, Seung Hyun Moon, et al.
Journal of Clinical Microbiology|November 8, 2019
False-Positive Results for Human Immunodeficiency Virus Type 1 Nucleic Acid Amplification Testing in Chimeric Antigen Receptor T Cell TherapyJocelyn R Hauser, Hong Hong, N Esther Babady, et al.
Pageof 10